No Detail Found!

Risk f actors and clinical asp ects of hep atitis b and c in p atients of nas irabad dis trict, Balochistan

Author(s)
Baz Muhammad Department of Paeds Medicine, Bolan Medical Complex and Hospital (BMCH), Quetta, Pakistan
Sana Ullah Department of Zoology, University, of Balochistan (UOB), Quetta, Pakistan
Hasina Jan Department of General Surgery, Bolan Medical Complex and Hospital (BMCH), Quetta, Pakistan
Bakhtawar Gul Kakar Department of Medicine & Allied, Bolan Medical Complex and Hospital (BMCH), Quetta, Pakistan
Amin Ullah Department of General Medicine, Bolan Medical Complex and Hospital (BMCH), Quetta, Pakistan
Inayat Ullah Department of Paediatrics, Children Hospital Quetta (CHQ), Quetta, Pakistan
Abstract
Objective: This study aimed to assess the prevalence of hepatitis B (HBV) a nd hepatitis C (HCV) infections in the local population of Nasiraba d District in Baloch istan, Pakistan. It also investigated sociodemog raph ic cha racteristics, associa ted risk facto rs, and cl inical a s well as subcl inical ma nifestations of these infectio ns. Methodology: This observational resea rch was carried out between August 2022 and November 2022. Data col lection took place at the Depa rtments of General Surgery and Pediatrics in Quetta 's Bolan Medical Complex Hospital (BMCH) a nd District Hea dqua rters Ho spitals in Nasira bad Division, Baloch ista n, Pakistan. A to tal of 523 pa rticipants (291 males and 232 females) underwent screening tests fo r HBV a nd HCV using ELISA and ICT methods. Pa rticipa nts were selected sequentially. Diagnosis of ch ronic liver disea se was based on a co mbina tio n of medical h isto ry, cl inical evaluation, ultrasound findings, and abno rmal l iv er function tests. Results: HCV exhibited a significa ntly higher prevalence a t 14.3% co mpa red to the 6.7% prevalence of HBsAg. The prevalence of HBsAg va ried by age gro ups, with the highest prevalence of 13.7% observed in indiv iduals under 30. Among those aged 31 to 40, prevalence rates of 7%, 5%, 13%, and 13% were noted. Fo r indiv iduals aged 51 to 60, the prevalence rema ined a t 13%. In the case of HCV, the prevalence also showed age -related va ria tio ns. The under-30 age group had a prevalence of 14.3%. The 31-40 age group showed a prevalence of 10%, and for indiv iduals aged 51 to 60, prevalence ra tes of 18.7%, 18.5%, a nd 18.7% were observed. These dispa rities in prevalence across different age g roups undersco re the significance of age-related facto rs a nd risk ex posure in the transmission of these hepatitis viruses. Public health interventio ns a nd medical ma nagement strateg ies should consider these variations. Conclusion: To enhance public awareness of the ro utes of viral hepatitis transmissio n and prevention stra tegies, co mprehensive co mmunity-based health education ca mpa igns a re imperative. Collabora tio n with healthca re professionals and the relevant autho rities respo nsible for co mbating infectio us diseases is essential to mitigate risk facto rs, such as sha ring razo rs and ex posure to unsafe medical injections.
Publication Details
Page(s) 285-294
Published Journal: Pak-Euro Journal of Medical and Life Sciences, Volume: 6, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Risk Factors, Hepatitis B, Hepatitis C, Clinical aspects, Nasirabad
0

Citations

0

Downloads

25

Views